| Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Medical services revenue | - | - | - | 6,048 |
|---|
| Other operating revenue | - | - | - | 13 |
|---|
| Total revenues | 1,834 | 2,708 | 4,316 | 6,061 |
|---|
| Medical services revenue | - | - | - | 5,843 |
|---|
| Other operating revenue | - | - | - | 213 |
|---|
| General and administrative | 456 | 219 | 286 | 269 |
|---|
| Depreciation and amortization | 15 | 14 | 20 | 24 |
|---|
| Impairments | - | - | - | 4 |
|---|
| Total expenses | - | - | 4,548 | 6,353 |
|---|
| Income (loss) from operations | -394 | -120 | -232 | -292 |
|---|
| Income (loss) from equity method investments | -7 | 11 | 16 | 15 |
|---|
| Other income (expense), net | -4 | 25 | 28 | 34 |
|---|
| Gain (loss) on lease terminations | - | -5 | - | - |
|---|
| Interest expense | - | - | - | 6 |
|---|
| Income (loss) before income taxes | -405 | -106 | -194 | -249 |
|---|
| Income tax benefit (expense) | 1 | 2 | 1 | 1 |
|---|
| Income (loss) from continuing operations | -405 | -107 | -195 | -250 |
|---|
| Income (loss) before gain (loss) on sales and income taxes | -3 | 0 | -20 | -1 |
|---|
| Gain (loss) on sales of assets, net | - | - | - | -9 |
|---|
| Income tax benefit (expense) | -2 | 0 | - | - |
|---|
| Total discontinued operations | -1 | 0 | -68 | -10 |
|---|
| Net income (loss) | -407 | -107 | -263 | -260 |
|---|
| Noncontrolling interests’ share in (earnings) loss | -0 | -0 | -0 | 0 |
|---|
| Net income (loss) attributable to common shares | -406 | -107 | -263 | -260 |
|---|
| Continuing operations basic (in dollars per share) | - | -0.26 | -0.48 | -0.61 |
|---|
| Continuing operations diluted (in dollars per share) | - | -0.26 | -0.48 | -0.61 |
|---|
| Discontinued operations basic (in dollars per share) | - | - | -0.16 | -0.02 |
|---|
| Discontinued operations diluted (in dollars per share) | - | - | -0.16 | -0.02 |
|---|